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ABSTRACT
Introduction: Maternal mental health has been largely
neglected in the literature. Women, however, may be
vulnerable to developing post-traumatic stress
symptoms or post-traumatic stress disorder (PTSD),
following traumatic birth. In turn, this may affect their
capacity for child rearing and ability to form a secure
bond with their baby and impact on the wider family.
Trauma-focused psychological therapies (TFPT) are
widely regarded as effective and acceptable
interventions for PTSD in general and clinical
populations. Relatively little is known about the
effectiveness of TFPT for women postpartum who have
post-traumatic stress symptoms.
Methods and analysis: We will conduct a review to
assess the effectiveness of TFPT, compared with usual
postpartum care, as a treatment for post-traumatic
stress symptoms or PTSD for women following
traumatic birth. Using a priori search criteria, we will
search for randomised controlled trials (RCT) in four
databases: Cochrane Central Register of Controlled
Trials (CENTRAL), MEDLINE, PsycINFO and OpenGrey.
We will use search terms that relate to the population,
TFPT and comparators. Screening of search results and
data extraction will be undertaken by two reviewers,
independently. Risk of bias will be assessed in RCTs
which meet the review criteria. Data will be analysed
using the following methods, as appropriate: narrative
synthesis; meta-analysis; subgroup analysis and meta-
regression.
Dissemination and ethics: As this work comprises
a synthesis of existing studies, ethical approvals are
not required. Results will be disseminated at
conferences and in publications.
INTRODUCTION
Maternal mental health remains relatively
underexplored despite the potential long-
term impact and consequences for women,
their babies and the wider family network.1–4
A recent confidential enquiry into maternal
deaths and morbidity in the UK and Ireland5
reported that mental health problems
remain one of the leading causes of maternal
death: from 2009 to 2013, 23% of deaths in
women postpartum (ranging from 6 weeks to
1 year after pregnancy) were attributed to
either suicide or accidental death (eg, follow-
ing substance misuse). The most common
maternal mental health problem diagnosed
during the postnatal period is depression.6 It
has been suggested, however, that the term
‘postnatal depression’ is overused in clinical
practice as a label for any mental illness
occurring postnatally.7
It is increasingly recognised that a trau-
matic birth can result in post-traumatic stress
symptoms (ie, symptoms that fall below the
diagnostic threshold), or post-traumatic stress
disorder (PTSD).8 9 PTSD is a severe and
debilitating mental health disorder that an
individual may develop in response to
Strengths and limitations of this study
▪ Using a comprehensive literature search and syn-
thesis, this systematic review will provide the
best evidence available regarding the effective-
ness of trauma-focused psychological therapies
for women who have suffered a traumatic birth
experience.
▪ The systematic review protocol was developed
and published prior to conducting the review to
avoid reporting bias.
▪ There may be some issues related to data (incor-
rect reporting, missing or insufficient data), but
we will contact the original researchers to ask for
the clarification, if necessary.
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experiencing or witnessing a highly traumatic event.10
For some women, giving birth can be a frightening,
anxiety-provoking and traumatic experience.
Perceptions of childbirth as traumatic arise when a
woman believes that there is a serious or significant
threat to her own life (eg, anticipated or unexpected
obstetric complications, emergency caesarean section)
or the life of her baby (eg, premature labour, still-
birth).11 12 PTSD symptoms that may occur in women
after a traumatic birth include intrusive thoughts and
images about the traumatic event (eg, seeing severe
blood loss, being rushed to hospital); avoidance of
stimuli associated with the traumatic event (eg, avoiding
attending hospital appointments or sharing birth experi-
ences with others; avoiding the baby who is a reminder
of the trauma); blunting of affect (eg, low mood); nega-
tive thoughts and beliefs about the self, others or the
world (eg, ‘I am going to die’, ‘I am not a good
mother’); dissociative states and emotional dysregula-
tion. PTSD symptoms can typically impede aspects of
daily functioning, including social relationships and
ability to find and sustain employment.
It is estimated that the proportion of women who
suffer post-traumatic stress symptoms following ‘normal’
childbirth is about 3–6% at around 6 weeks postpartum,
decreasing to about 1.5% at 6 months postpartum.13
Prevalence rates appear to be higher for at-risk groups
(eg, women who have experienced obstetric complica-
tions, emergency caesarean sections, premature
births or stillbirths) and are estimated to be up to 44%
within 2 years postpartum.14 However, prevalence esti-
mates vary widely, perhaps due to differences in study
designs, sampling frames, sample sizes, diagnostic cri-
teria employed and measurement instruments.14–16 It is
anticipated that the number of women who experience
traumatic births is likely to rise, due to increasingly
complex medical needs of women who become
pregnant when older or obese.17–20 There is, therefore,
an urgent need to consider how best to support women
who suffer from post-traumatic stress symptoms during
the postnatal period.
Description of the intervention
Systematic reviews have consistently concluded that
trauma-focused psychological therapies (TFPT) are
effective treatments for PTSD in general population
groups. These include different modes of exposure
therapy such as narrative exposure therapy (NET),
trauma-focused cognitive–behavioural therapy (TFCBT)
and eye-movement desensitisation and reprocessing
(EMDR).21–23 All TFPT share some core treatment prin-
ciples, in particular, an emphasis on supporting patients
to make sense of and process memories of trauma, and
cognitions and attributions relating to traumatic
events.24–26 EMDR27 and CBT, in particular, are recom-
mended by NICE guidance on PTSD for children and
adults who have experienced a single traumatic event.23
How the intervention might work
Exposure therapy typically involves asking the individual
to relive the trauma, either in their imagination or by
writing (in NET) a trauma narrative to create a detailed
account of the event. The individual is then asked
repeatedly to revisit or read the narrative in order to
become habituated to the post-traumatic stress symptoms
that are generated.24 28 TFCBT involves helping indivi-
duals to make sense of their experiences, identify ways
or patterns of thinking that are negative, recognise
thoughts and beliefs about the self, others or the world
that are associated with the traumatic event, and finally,
note behavioural or coping responses which may be
helpful in the short term, yet perpetuate anxiety in the
longer term. Individuals are encouraged to develop new
ways of thinking about and appraising traumatic
events.29 EMDR involves supporting individuals to iden-
tify and then focus on a traumatic image (eg, finding
oneself with heavy bleeding), an associated thought (eg,
‘My baby and I are going to die’), the emotion (eg,
extreme fear) and physical sensations, while receiving
bilateral stimulation, most commonly in the form of eye
movements.27
Importance of the review
Although TFPT are effective and acceptable as treat-
ments for PTSD in general and clinical populations,
postpartum women are typically excluded from research
studies, so the clinical utility of these interventions is yet
to be established.2 There is currently no systematic
review that synthesises evidence regarding the effective-
ness of TFPT for women who have suffered a traumatic
birth. A Cochrane review of psychosocial and psycho-
logical interventions (eg, CBT) for postnatal depression
does exist,30 31 but PTSD and trauma symptoms are not
included as outcomes of interest. It is quite possible that
PTSD following childbirth differs from PTSD that occurs
in other contexts.32 Unlike typical stressors that contrib-
ute to PTSD, such as abuse, assault, torture and war,
childbirth is by and large deemed to be a positive event,
while also concurrently seeming traumatic for some
women. The implication is that women’s needs may be
misunderstood.33 Behaviours indicative of PTSD, such as
social withdrawal and avoidance, may be misattributed to
needing to care for a baby, when in fact this is as a con-
sequence of PTSD. It is also evident that for some
women caring for a baby continues to be a reminder of
traumatic experiences, which may in turn mediate the
propensity for developing strong bonds and secure
attachments between mother and child. Overall, it is
likely to be clinically important to take account of the
postnatal context when planning and delivering TFPT.
OBJECTIVES
The primary objective of this systematic review is to
assess the effectiveness of TFPT, compared with usual
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postpartum care for PTSD or post-traumatic stress symp-
toms in women following traumatic birth.
Secondary objectives are to examine the effectiveness
of these psychological interventions for common
comorbid symptoms including depression, anxiety or
distress, as well as any adverse effects including an
increase in PTSD symptoms or death.
METHOD AND ANALYSIS
Inclusion/exclusion criteria
Population
Women experiencing post-traumatic stress symptoms and/
or the impact of these following traumatic birth, who meet
PTSD diagnostic threshold, or who have subthreshold
symptoms. Diagnostic assessment could be made accord-
ing to self-report, such as via a questionnaire (eg, PTSD
Symptom Scale—Self Report version (PSS-SR)34), or via a
clinician-administered assessment (eg, Structured Clinical
Interview for DSM-IV (SCID)35 36); Clinician-administered
PTSD Scale (CAPS)37). There is no restriction on age,
nationality or birth mode.
Intervention
TFPT added to usual (standard) postnatal care to
reduce symptoms of PTSD. Psychological interventions
that will be included in this review are as follows:
1. Exposure therapy: Any individual therapy which
involves guiding the individual to relive and process
the trauma memory through creating a narrative
using formats such as writing or audio-recording.
During therapy, the patient will revisit the narrative
repeatedly in order to habituate or develop tolerance
of trauma symptoms.
2. Trauma-focused cognitive–behavioural therapy (TFCBT):
Any psychological therapy that predominantly employs
trauma-focused cognitive, behavioural or cognitive–
behavioural techniques and that aim to support indivi-
duals to identify unhelpful thoughts or thinking styles,
and behaviours, and develop new ways of thinking
about or coping with trauma. Examples of therapies
within this category are cognitive therapy,29 cognitive
processing therapy38 and prolonged exposure.39
3. EMDR: A structured protocol-driven trauma-focused
therapy, which relies on an adaptive information
process model of PTSD.40 EMDR comprises eight ele-
ments, including recall of images, thoughts, emotions
and bodily sensations associated with traumatic
events, while receiving bilateral stimulation.
4. Any other psychological intervention that does not fit
the above categories, but clearly describes the theor-
etical underpinning and is intended to target trauma
symptoms and related distress in postpartum females.
Comparators
1. Standard postnatal care (which denotes the usual
postnatal care provided within the first 6 weeks post-
birth in settings which do not routinely offer TFPT).
2. Standard postnatal care, plus any non-specific support-
ive counselling or ‘attention control’ (eg, befriending)
provided by primary care/postnatal follow-up.
Types of outcome measures
Primary outcome
Recovery (dichotomous outcomes) from, or reduction
(continuous outcomes) in PTSD or trauma symptoms as
measured by validated scales, for example, PSS-SR,34
CAPS,37 Impact of Events Scale (IES).41 Scores of con-
tinuous outcome measures reported, such as PSS-SR and
CAPS, will be converted to indicate recovery or not from
PTSD according to well-established cut-off scores (eg,
cut-off scores for the PSS-SR, the CAPS and the IES are
14, 40 and 19) or as described by the study authors.
Secondary outcomes
▸ Recovery (dichotomous outcomes) from, or reduc-
tion (continuous outcomes) in depressive symptoms
as measured by validated scales, for example,
Edinburgh Postnatal Depression Scale (EPDS),42
Beck Depression Inventory (BDI),43 State of Anxiety
and Depression (SAD).44
▸ Recovery (dichotomous outcomes) from, or reduc-
tion (continuous outcomes) in anxiety symptoms as
measured by validated scales, for example, Beck
Anxiety Inventory (BAI),45 Hospital Anxiety and
Depression Scale.46
▸ Well-being or quality of life, for example, Short
Form-36 (SF-36).47
▸ Adverse events or effects, for example, increased
PTSD or trauma symptom severity, death.
Timing of outcome measurements
Timing of outcome measurements will be grouped into
three periods of time:
Short term: up to 6 months post-intervention;
Medium term: between 6 and 12 months
post-intervention
Long term: over 12 months post-intervention.
Types of studies
We will include all randomised controlled trials (RCTs),
cluster RCTs, quasi-randomised trials (such as trials
which allocate study participants according to day of the
week), and RCTs that comprise a cross-over method-
ology that compare TFPT for PTSD symptoms in women
following traumatic birth with usual postpartum care.
Study populations which comprise non-postpartum indi-
viduals will be included if the subset of data specific to
the women are published or obtainable from the paper/
trialists. There will be no restriction based on the study
sample size, language, study setting or publication status.
Data sources and search strategy
We will carry out systematic searches in the Cochrane
Central Register of Controlled Trials (CENTRAL),
MEDLINE, PsycINFO and OpenGrey using a search
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strategy developed in consultation with an information
specialist at the academic institution where the first
reviewer (MF) is based (table 1). To maximise search
sensitivity, we will use index terms (eg, Medical Subject
Heading: MeSH) and free-text terms referring to popu-
lation (eg, ‘pregnancy’, ‘postnatal’) and interventions
(eg, ‘Cognitive Therapy’, ‘Eye Movement Desensitisation
Reprocessing’) without terms referring to outcomes. No
restrictions on date, language or publication status will
be applied to the searches. The electronic searches will
be supplemented by a hand search of the reference lists
of all included studies. The citations we retrieve from
the searches will be imported into the reference man-
agement software package EndNote X7.
Data collection and analysis
Selection of studies
Two reviewers will independently screen titles and
abstracts of all potential studies identified through the
search strategy, and they will code them as ‘retrieve’ (eli-
gible or potentially eligible/unclear) or ‘do not
retrieve’. The two reviewers will then independently
read the full text of the studies retrieved to determine
whether trials meet the inclusion criteria or to record
reasons for excluding ineligible studies. A third author
will undertake a random check of 10% of results at each
stage. Any disagreements will be resolved through discus-
sion or, if required, through consultation with other
review authors. The process of the study selection will be
outlined in a Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) flow diagram and
‘characteristics of excluded studies’ table.
Data extraction and management
Two review authors will independently extract data using
a data extraction form designed for this review which
include details about study eligibility; sample frame and
size; participant characteristics; diagnosis and diagnostic
Table 1 Searching strategy (MEDLINE)
Population AND Intervention AND Study design*
exp Pregnancy/ exp Cognitive Therapy/ exp Clinical Trial/
OR OR OR
exp Pregnancy Outcome/ CBT.mp. exp Clinical Trial, phase I/
OR OR OR
exp Delivery, Obstetric/ exp Eye Movement Desensitization
Reprocessing/
exp Clinical Trial, phase II/
OR OR OR
exp Parturition/ EMDR exp Clinical Trial, phase III/
OR OR OR
birth.mp exp Behavior Therapy/ exp Clinical Trial, phase IV/
OR OR OR
childbirth.mp Behaviour* therapy.mp exp Controlled Clinical Trial/
OR OR OR
exp Postnatal Care/ exp Psychotherapy/ exp Randomized Controlled
Trial/
OR OR OR
postnatal.mp psychological.mp exp Random Allocation/
OR OR OR
exp Postpartum Period/ exp Psychological Techniques/ randomised.mp
OR OR OR
postpartum.mp exp Psychology, Experimental/ trial.mp
OR OR OR
exp Maternal Health Services/ Trauma focused.mp RCT.mp
OR
exp Infant, Newborn/
OR
exp Caesarean Section/
OR
caesarean
OR
exp Stillbirth/
exp Intensive Care, Neonatal/
OR
exp Intensive Care Units,
Neonatal/
*Search will be performed initially with sets of terms referring to population and interventions. The terms referring to study design may be
added if necessary to increase search specificity.
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criteria used; nature, timing and duration of interven-
tion; number and frequency of sessions; professional
background of trial therapists; outcomes (primary and
secondary measures); statistical analyses; duration of
follow-up and attrition. Attempts will be made to obtain
missing and/or unpublished details, by contacting study
authors. This process will involve contacting trialists for
independent data sets of postnatal women, if they are
included in trials that also include other trauma victims.
Risk of bias assessment
Two review authors will independently assess the risk of
bias of all included studies, using the approach recom-
mended in the Cochrane Handbook for Systematic Review of
Interventions.48 The Cochrane’s risk-of-bias tool addresses
six specific domains: (1) sequence allocation for ran-
domisation; (2) allocation concealment; (3) blinding of
personnel and assessors; (4) incomplete outcome data;
(5) selective reporting and (6) any other notable risks of
bias. For each item, one of the following three judge-
ments will be made: ‘low risk’ of bias (plausible bias—
unlikely to seriously alter the results), ‘high risk’ of bias
(plausible bias that seriously weakens confidence in the
results) or ‘unclear risk’ of bias (plausible bias that
raises some doubt about the results) when insufficient
information was reported to permit judgement. The
process for reaching judgments will be described in the
risk-of-bias tables to ensure transparency.
Summary assessments of risk of bias
The overall quality of the evidence for each outcome
will be assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
approach.48 49 The overall quality of evidence for each
outcome will be assigned to one of four levels—high,
moderate, low or very low—according to factors includ-
ing within-study risk of bias (methodological quality),
directness of evidence, heterogeneity, precision of effect
estimates and risk of publication bias.48 49
Measures of treatment effect
For dichotomous outcomes, such as the presence of
PTSD, depression or anxiety, the Mantel-Haenszel
method for computing the pooled risk ratio (RR) with
95% CIs will be used. For continuous data, and where
different scales have been used, the standardised mean
difference (SMD) and 95% CI will be calculated to indi-
cate the direction and consistency of effect. The
weighted mean difference (WMD) and 95% CI will be
calculated where all outcomes were measured using the
same scale in the same way.
Multiplicity and unit of analysis issues
If a study reports data for more than one outcome or
time-point, analyses will be conducted separately for
each outcome/time-point (short, medium, long term).
For trials with multiple arms of treatment in a study, the
appropriateness of combining data to create a single
pair-wise comparison will be considered if therapies are
sufficiently similar. Alternatively, data from the arms of
the trial which fit closest to the review objectives will be
used. Where studies have adopted a cross-over design,
only outcome data from the first randomisation period
will be included. If cluster-randomised trials are identi-
fied, sample sizes will be adjusted using an estimate of
the intracluster correlation coefficient (ICC) from the
trial or from a study of a similar population, based on
statistical advice.
Dealing with missing data
Dealing with missing data may include imputing out-
comes for the missing participants to facilitate an
intention-to-treat (ITT) analysis.48 This may involve a
sensitivity analysis by imputing outcomes for the missing
participants with the most optimistic and the most pes-
simistic scenarios and then comparing the results of
these two analyses. The sensitivity analysis may also be
conducted to facilitate comparisons of the ITT with
imputations from ‘available case analysis’ (ie, analyse
data with participants whose outcomes are known).48 If
these analyses yield similar results in the same direction
of the effects of the treatment (indicating participants
with missing outcomes are safely excluded), the results
of available case analysis will be used for meta-analysis.
The impact of including these studies in the overall
assessment of treatment effect (summary effect) will be
further assessed with additional sensitivity analysis com-
paring the results of meta-analyses with and without
trials which are rated as high risk bias due to missing
data (see Sensitivity analysis).
Assessment of reporting biases
When sufficient studies are available (n=10 or more), we
will construct funnel plots and scrutinised them for
signs of asymmetry.48
Data synthesis
Random effects meta-analyses will be performed which
will produce the average effect size of the intervention
across studies, allowing for differences in the treatment
effect from study to study. Random effects meta-analyses
is a conservative option and more appropriate for this
study than a fixed-effect model (which assumes that
there is one true effect), because the populations and
settings are likely to be slightly different, therefore the
effects are likely to be slightly different. However, if
there are only few studies (two to four studies), it may
be inadequate to accurately estimate of the width of the
distribution of intervention effects.48 50 In this case, a
fixed-effect analysis will be performed. Then, the
results obtained from these two methods random effects
and fixed-effect models will be compared to seek poten-
tial bias and heterogeneity. Analyses will be conducted
by a statistician (ESWN) using a statistical software,
STATAV.14.
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Heterogeneity
Heterogeneity will be assessed within each comparison.
In the instance of clinical heterogeneity (eg, variation in
study settings, intervention modality), we will conduct
subgroup analyses. Alternatively, if there is methodo-
logical heterogeneity (eg, variation in study designs,
outcome measures or risk of bias), we will perform sensi-
tivity analyses, where data are available. If there is signifi-
cant heterogeneity between studies, extracted data will
be synthesised into a narrative summary.
Where meta-analyses are performed, tests of statistical
heterogeneity will be carried out using I2 and χ2 statis-
tics,48 as well as visual inspection of the forest plots. If
heterogeneity is identified (eg, the I2 is >30%, and the p
value is <0.10 in the χ2 test for heterogeneity or different
direction of the effects), prespecified subgroup analysis
and meta-regression analyses will be conducted to iden-
tify important determinants of heterogeneity when suffi-
cient data are available.
Subgroup analysis and meta-regression
If possible, subgroup analyses will be undertaken as follows:
1. Study setting (high-income vs middle-income vs low-
income countries).
2. Delivery mode of the intervention which shares the
same theoretical modality (eg, face-to-face vs web-
based TFCBT).
Meta-regression analysis
1. Intervention frequency (eg, number of sessions).
2. Methodological heterogeneity of trial (eg, ways of
dealing with missing data, whether effect estimates
from ‘per-protocol’ analyses differ compared with
‘ITT’ analyses).
Sensitivity analysis
Sensitivity analyses will be conducted to assess the effects
of quality of trial methodology by comparing the results
of meta-analyses with and without trials that are judged to
have a high risk of bias for one or more of the domains of
random sequence generation, allocation concealment,
blinding of outcome assessment or incomplete outcome.
A sensitivity analysis will also be conducted to examine
potential bias caused by missing data, by comparing
results from different methods of dealing with missing
data (eg, available case analysis, ITT analysis using
imputation of outcomes, assuming that all missing parti-
cipants had positive outcome or that all missing partici-
pant had negative outcomes). Results of sensitivity will
be reported in a summary of findings table.
Ethics and dissemination
Ethical approval is not required to conduct systematic
reviews. The protocol was registered in PROSPERO
(CRD42016043897). The findings of the review will be
presented at relevant national and international confer-
ences and submitted to a peer-reviewed journal.
DISCUSSION
There is a lack of acknowledgement that women post-
partum may be at risk of developing symptoms of
trauma or PTSD. This means that their mental health
needs likely remain undetected and unmet and, import-
antly, symptoms may impact on childcare and rearing.
Women are not routinely included in studies investigat-
ing the effectiveness of psychological interventions for
PTSD, and therefore we know little about whether these
interventions are effective and acceptable to this popula-
tion. We believe that this systematic review will be a valu-
able contribution to improving women’s mental health
and well-being following childbirth.
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